Yun Chen

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 584 citations

Medicine, Oncology, Pharmacology +14

Development of a Porcine Bladder Acellular Matrix with Well-Preserved Extracellular Bioactive Factors for Tissue Engineering

Bin Yang, Yifen Zhang, Liuhua Zhou et al. · Tissue Engineering Part C Methods · 2010 · 206 citations

Engineering, Bioengineering, Biomedical Engineering +17

Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations

Jiaying Deng, Hu Chen, Daizhan Zhou et al. · Nature Communications · 2017 · 131 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Patterns of distant organ metastases in esophageal cancer: a population-based study

Dashan Ai, Hanting Zhu, Wenjia Ren et al. · Journal of Thoracic Disease · 2017 · 115 citations · Full text

Medicine, Biostatistics, Oncology +16

Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial

Qi Liu, Junqiang Chen, Lin Yu et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 77 citations

Medicine, Oncology, Surgical Oncology +8